Technical Analysis for ZNTL - Zentalis Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
D 3.13 4.68% 0.14
ZNTL closed up 4.68 percent on Wednesday, November 20, 2024, on 50 percent of normal volume.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
NR7 Range Contraction 4.68%
Narrow Range Bar Range Contraction 4.68%
Wide Bands Range Expansion 4.68%
Down 3 Days in a Row Weakness 4.68%
Fell Below 20 DMA Bearish 2.62%
Fell Below 50 DMA Bearish 2.62%
MACD Bearish Signal Line Cross Bearish 2.62%
New Downtrend Bearish 2.62%

   Recent Intraday Alerts

Alert Time
Up 5% about 22 hours ago
Rose Above Previous Day's High about 22 hours ago
Outside Day about 22 hours ago
Up 3% about 22 hours ago
Up 2% about 22 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Zentalis Pharmaceuticals LLC is a clinical-stage biopharmaceutical company focused on discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. Its lead product candidate, ZN-c5, is an oral selective estrogen receptor degrader (SERD) for the treatment of estrogen receptor positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) advanced or metastatic breast cancer. The company was founded by Kevin Bunker on December 23, 2014 and is headquartered in New York, NY.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Drugs Breast Cancer Treatment Of Breast Cancer Epidermal Growth Factor Receptor Hormones Tyrosine Kinase Receptors Her2 Her2/Neu Molecule Therapeutics Transcription Factors Estrogen Antiestrogens Estrogen Receptor Receptor Positive Selective Estrogen Receptor Degraders Metastatic Breast Cancer

Is ZNTL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 18.07
52 Week Low 2.66
Average Volume 2,367,846
200-Day Moving Average 7.77
50-Day Moving Average 3.42
20-Day Moving Average 3.39
10-Day Moving Average 3.60
Average True Range 0.36
RSI (14) 44.13
ADX 24.79
+DI 24.79
-DI 24.06
Chandelier Exit (Long, 3 ATRs) 3.36
Chandelier Exit (Short, 3 ATRs) 3.74
Upper Bollinger Bands 4.32
Lower Bollinger Band 2.45
Percent B (%b) 0.36
BandWidth 55.14
MACD Line 0.02
MACD Signal Line 0.08
MACD Histogram -0.0657
Fundamentals Value
Market Cap 221.5 Million
Num Shares 70.8 Million
EPS -4.56
Price-to-Earnings (P/E) Ratio -0.69
Price-to-Sales 0.00
Price-to-Book 1.69
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.58
Resistance 3 (R3) 3.55 3.38 3.51
Resistance 2 (R2) 3.38 3.26 3.39 3.48
Resistance 1 (R1) 3.25 3.19 3.32 3.28 3.45
Pivot Point 3.08 3.08 3.11 3.09 3.08
Support 1 (S1) 2.95 2.96 3.02 2.98 2.81
Support 2 (S2) 2.78 2.89 2.79 2.78
Support 3 (S3) 2.65 2.78 2.76
Support 4 (S4) 2.68